Biopharmaceuticals in South East Asia

Summary

This detailed report analyses the market and research environments, assessing risk and identifying opportunity in Indonesia, Malaysia, Singapore, South Korea, Taiwan and Thailand.
Providing, A thorough review of the burgeoning market for biopharmaceutical drugs in SE Asia

An examination of the markets in terms of investment and research opportunities

Market forecasts to 2013 for biopharmaceuticals

A review of over 65 local companies/ organisations developing biopharmaceutical products

Markets covered

• Indonesia
• Malaysia
• Singapore
• South Korea
• Taiwan
• Thailand

Content